Amiodaron je organsko jedinjenje, koje sadrži 25 atoma ugljenika i ima molekulsku masu od 645,312 Da.[1][2][3][4][5][6][7]

Amiodaron
Klinički podaci
Prodajno imeAminodarone, Amio-Aqueous IV, Amiodarons, Aratac
Drugs.comMonografija
Način primeneIntravenozno, oralno
Farmakokinetički podaci
Poluvreme eliminacije58 dana
IzlučivanjeRenaln o
Identifikatori
CAS broj1951-25-3 Зелена квачицаДа
ATC kodC01BD01 (WHO)
PubChemCID 2157
IUPHAR/BPS2566
DrugBankDB01118 Зелена квачицаДа
ChemSpider2072 Зелена квачицаДа
KEGGC06823 Зелена квачицаДа
ChEBICHEBI:2663 Зелена квачицаДа
ChEMBLCHEMBL633 Зелена квачицаДа
Hemijski podaci
FormulaC25H29I2NO3
Molarna masa645,312
  • CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=CC=CC=C2O1
  • InChI=1S/C25H29I2NO3/c1-4-7-11-22-23(18-10-8-9-12-21(18)31-22)24(29)17-15-19(26)25(20(27)16-17)30-14-13-28(5-2)6-3/h8-10,12,15-16H,4-7,11,13-14H2,1-3H3 Зелена квачицаДа
  • Key:IYIKLHRQXLHMJQ-UHFFFAOYSA-N Зелена квачицаДа
Osobina Vrednost
Broj akceptora vodonika 3
Broj donora vodonika 0
Broj rotacionih veza 11
Particioni koeficijent[8] (ALogP) 7,2
Rastvorljivost[9] (logS, log(mol/L)) -10,3
Polarna površina[10] (PSA, Å2) 42,7

Reference

уреди
  1. ^ DELTOUR G, BINON F, TONDEUR R, GOLDENBERG C, HENAUX F, SION R, DERAY E, CHARLIER R: [Studies in the benzofuran series. VI. Coronary-dilating activity of alkylated and aminoalkylated derivatives of 3-benzoylbenzofuran.] Arch Int Pharmacodyn Ther. 1962 Sep 1;139:247-54. DELTOUR, G; BINON, F.; TONDEUR, R; GOLDENBERG, C.; HENAUX, F; SION, R.; DERAY, E; CHARLIER, R. (1962). . „Studies in the benzofuran series. VI. Coronary-dilating activity of alkylated and aminoalkylated derivatives of 3-benzoylbenzofuran”. Archives Internationales de Pharmacodynamie et de Therapie. 139: 247—254. PMID 14026835. 
  2. ^ CHARLIER R, DELTOUR G, TONDEUR R, BINON F: [Studies in the benzofuran series. VII. Preliminary pharmacological study of 2-butyl-3-(3,5-diiodo-4-beta-N-diethylaminoethoxybenzoyl)-benzofuran.] Arch Int Pharmacodyn Ther. 1962 Sep 1;139:255-64. CHARLIER, R; DELTOUR, G.; TONDEUR, R; BINON, F. (1962). . „Studies in the benzofuran series. VII. Preliminary pharmacological study of 2-butyl-3-(3,5-diiodo-4-beta-N-diethylaminoethoxybenzoyl)-benzofuran”. Archives Internationales de Pharmacodynamie et de Therapie. 139: 255—264. PMID 14020244. 
  3. ^ Singh, B. N.; Vaughan Williams EM (1970 Aug). . „The effect of amiodarone, a new anti-anginal drug, on cardiac muscle”. Br J Pharmacol. 39 (4): 657—67. PMC 1702721 . PMID 5485142. doi:10.1111/j.1476-5381.1970.tb09891.x.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  4. ^ Rosenbaum, M. B.; Chiale PA; Halpern MS; Nau GJ; Przybylski J; Levi RJ, Lazzari JO, Elizari MV (1976 Dec). . „Clinical efficacy of amiodarone as an antiarrhythmic agent”. Am J Cardiol. 38 (7): 934—44. PMID 793369. doi:10.1016/0002-9149(76)90807-9.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  5. ^ Rosenbaum MB, Chiale PA, Haedo A, Lazzari JO, Elizari MV: Ten years of experience with amiodarone. Am Heart J. 1983 Oct;106(4 Pt 2):957-64. Rosenbaum, M. B.; Chiale, P. A.; Haedo, A.; Lázzari, J. O.; Elizari, M. V. (1983). . „Ten years of experience with amiodarone”. American Heart Journal. 106 (4 Pt 2): 957—964. PMID 6613843. doi:10.1016/0002-8703(83)90022-4. 
  6. ^ Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). . „DrugBank 3.0: A comprehensive resource for 'Omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—D1041. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126. 
  7. ^ Wishart, David S.; Knox, Craig; Guo, An Chi; Cheng, Dean; Shrivastava, Savita; Tzur, Dan; Gautam, Bijaya; Hassanali, Murtaza (2008). . „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—D906. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958. 
  8. ^ Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). . „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o. 
  9. ^ Tetko, Igor V.; Tanchuk, Vsevolod Yu.; Kasheva, Tamara N.; Villa, Alessandro E. P. (2001). . „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t. 
  10. ^ Ertl, Peter; Rohde, Bernhard; Selzer, Paul (2000). . „Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e. 

Literatura

уреди

Spoljašnje veze

уреди


 Molimo Vas, obratite pažnju na važno upozorenje
u vezi sa temama iz oblasti medicine (zdravlja).